Vicebio

Vicebio

Biotechnology Research

Delivering next generation of respiratory virus vaccines using the molecular clamp technology

About us

Vicebio uses the molecular clamp technology to develop innovative vaccines against life-threatening respiratory viruses. The Molecular Clamp technology provide unique stabilisation of viral envelop glycoproteins making possible highly effective, ready-to-use, and multivalent single shot respiratory virus vaccines.

Website
www.vicebio.com
Industry
Biotechnology Research
Company size
2-10 employees
Type
Self-Owned
Founded
2019
Specialties
Vaccines, Structural vaccinology, respiratory viruses, RSV, Influenza, SARS-Cov-2, Metapneumovirus, and Parainfluenza

Employees at Vicebio

Updates

Similar pages